Papa A - Search Results

1

COVID-19 infection in Crohn's disease under treatment with adalimumab.

Tursi A, Angarano G, Monno L, Saracino A, Signorile F, Ricciardi A, Papa A. Tursi A, et al. Among authors: papa a. Gut. 2020 Jul;69(7):1364-1365. doi: 10.1136/gutjnl-2020-321240. Epub 2020 Apr 20. Gut. 2020. PMID: 32312788 No abstract available.

2

Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-H. pylori therapy.

Cammarota G, Tursi A, Montalto M, Papa A, Branca G, Vecchio FM, Renzi C, Verzí A, Armuzzi A, Pretolani S, et al. Cammarota G, et al. Among authors: papa a. J Clin Gastroenterol. 1995 Sep;21(2):118-22. doi: 10.1097/00004836-199509000-00011. J Clin Gastroenterol. 1995. PMID: 8583076 Clinical Trial.

3

Role of dental plaque in the transmission of Helicobacter pylori infection.

Cammarota G, Tursi A, Montalto M, Papa A, Veneto G, Bernardi S, Boari A, Colizzi V, Fedeli G, Gasbarrini G. Cammarota G, et al. Among authors: papa a. J Clin Gastroenterol. 1996 Apr;22(3):174-7. doi: 10.1097/00004836-199604000-00004. J Clin Gastroenterol. 1996. PMID: 8724252

4

Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection.

Tursi A, Cammarota G, Montalto M, Papa A, Veneto G, Cuoco L, Trua F, Branca G, Fedeli G, Gasbarrini G. Tursi A, et al. Among authors: papa a. Aliment Pharmacol Ther. 1996 Jun;10(3):285-8. doi: 10.1111/j.0953-0673.1996.00285.x. Aliment Pharmacol Ther. 1996. PMID: 8791952 Clinical Trial.

5

Helicobacter pylori eradication helps resolve pyloric and duodenal stenosis.

Tursi A, Cammarota G, Papa A, Montalto M, Fedeli G, Gasbarrini G. Tursi A, et al. Among authors: papa a. J Clin Gastroenterol. 1996 Sep;23(2):157-8. doi: 10.1097/00004836-199609000-00020. J Clin Gastroenterol. 1996. PMID: 8877648 No abstract available.

6

One-week low-dose triple therapy vs. two-week medium-dose double therapy for H.pylori infection.

Tursi A, Cammarota G, Papa A, Montalto M, Veneto G, Capelli G, Cuoco L, Branca G, Fedeli G, Gasbarrini G. Tursi A, et al. Among authors: papa a. Hepatogastroenterology. 1996 Jul-Aug;43(10):859-62. Hepatogastroenterology. 1996. PMID: 8884304 Clinical Trial.

7

Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin.

Cammarota G, Tursi A, Papa A, Montalto M, Veneto G, Cuoco L, Fedeli G, Gasbarrini G. Cammarota G, et al. Among authors: papa a. Aliment Pharmacol Ther. 1996 Dec;10(6):997-1000. doi: 10.1046/j.1365-2036.1996.d01-533.x. Aliment Pharmacol Ther. 1996. PMID: 8971300 Clinical Trial.

8

The growth of primary low-grade B-cell gastric lymphoma is sustained by Helicobacter pylori.

Cammarota G, Tursi A, Papa A, Voso MT, Serra F, Chiusolo P, Fedeli G, Gasbarrini G. Cammarota G, et al. Among authors: papa a. Scand J Gastroenterol. 1997 Mar;32(3):285-7. doi: 10.3109/00365529709000208. Scand J Gastroenterol. 1997. PMID: 9085468

9

Effects of propylthiouracil on intestinal transit time and symptoms in hyperthyroid patients.

Papa A, Cammarota G, Tursi A, Certo M, Montalto M, Capelli G, de Rosa G, Cuoco L, Fedeli G, Gasbarrini G. Papa A, et al. Hepatogastroenterology. 1997 Mar-Apr;44(14):426-9. Hepatogastroenterology. 1997. PMID: 9164513

10

Long-term follow-up of disappearance of gastric mucosa-associated lymphoid tissue after anti-Helicobacter pylori therapy.

Tursi A, Cammarota G, Papa A, Cuoco L, Fedeli G, Gasbarrini G. Tursi A, et al. Among authors: papa a. Am J Gastroenterol. 1997 Oct;92(10):1849-52. Am J Gastroenterol. 1997. PMID: 9382050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,038 results

Search Page

Filters